1. Home
  2. TRVI vs NQP Comparison

TRVI vs NQP Comparison

Compare TRVI & NQP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • NQP
  • Stock Information
  • Founded
  • TRVI 2011
  • NQP 1990
  • Country
  • TRVI United States
  • NQP United States
  • Employees
  • TRVI N/A
  • NQP N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • NQP Trusts Except Educational Religious and Charitable
  • Sector
  • TRVI Health Care
  • NQP Finance
  • Exchange
  • TRVI Nasdaq
  • NQP Nasdaq
  • Market Cap
  • TRVI 383.4M
  • NQP 423.5M
  • IPO Year
  • TRVI 2019
  • NQP N/A
  • Fundamental
  • Price
  • TRVI $6.50
  • NQP $11.12
  • Analyst Decision
  • TRVI Strong Buy
  • NQP
  • Analyst Count
  • TRVI 8
  • NQP 0
  • Target Price
  • TRVI $17.56
  • NQP N/A
  • AVG Volume (30 Days)
  • TRVI 4.4M
  • NQP 58.4K
  • Earning Date
  • TRVI 03-18-2025
  • NQP 01-01-0001
  • Dividend Yield
  • TRVI N/A
  • NQP 3.21%
  • EPS Growth
  • TRVI N/A
  • NQP N/A
  • EPS
  • TRVI N/A
  • NQP N/A
  • Revenue
  • TRVI N/A
  • NQP N/A
  • Revenue This Year
  • TRVI N/A
  • NQP N/A
  • Revenue Next Year
  • TRVI N/A
  • NQP N/A
  • P/E Ratio
  • TRVI N/A
  • NQP N/A
  • Revenue Growth
  • TRVI N/A
  • NQP N/A
  • 52 Week Low
  • TRVI $2.30
  • NQP $9.65
  • 52 Week High
  • TRVI $7.39
  • NQP $11.89
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 66.37
  • NQP 30.56
  • Support Level
  • TRVI $6.22
  • NQP $11.11
  • Resistance Level
  • TRVI $6.79
  • NQP $11.45
  • Average True Range (ATR)
  • TRVI 0.40
  • NQP 0.08
  • MACD
  • TRVI -0.03
  • NQP -0.03
  • Stochastic Oscillator
  • TRVI 52.24
  • NQP 2.17

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About NQP Nuveen Pennsylvania Quality Municipal Income Fund

Nuveen Pennsylvania Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal and Pennsylvania income taxes and to enhance portfolio value relative to the municipal bond market by investing in municipal securities that are exempt from federal, Pennsylvania state and local income taxes. It invests a majority of its assets in securities that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: